Teehan Brendan — SEC Form 4 filings
SEC reporting owner CIK 1891900. 11 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-09 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 32,403 shares, $553,401 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 10,329 shares @ $16.81 ($173,630) in ACADIA PHARMACEUTICALS INC, filed 2024-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC (ACAD) | EVP, COO, HEAD OF COMMERCIAL | 7 | — | 7 legs · 32,403 sh · $553,401 | 17 |
| Pacira BioSciences, Inc. (PCRX) | Chief Commercial Officer | 4 | — | — | 5 |
Form 4 filings — Teehan Brendan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-13 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 51,714 @ $0 | EDGAR |
| 2026-02-03 | 4 | Pacira BioSciences, Inc. (PCRX) | Tax withholding (F): 5,182 @ $20.54 | EDGAR |
| 2026-01-06 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 402.27 @ $10.76 | EDGAR |
| 2025-02-04 | 4 | Pacira BioSciences, Inc. (PCRX) | Grant/award (A): 54,000 @ $0 · Grant/award (A): 99,500 (derivative) @ $26.59 | EDGAR |
| 2024-11-19 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 9,913 · Option exercise (M): 9,913 · Sale (S): 10,329 @ $16.81 · Option exercise (M): 9,913 (derivative) @ $0 · Option exercise (M): 9,913 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 5,024 @ $0 · Grant/award (A): 13,629 @ $0 · Sale (S): 9,534 @ $15.28 | EDGAR |
| 2024-05-03 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 6,814 · Sale (S): 3,477 @ $16.94 · Option exercise (M): 6,814 (derivative) @ $0 | EDGAR |
| 2024-04-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 5,024 · Sale (S): 2,568 @ $17.87 · Option exercise (M): 5,024 (derivative) @ $0 | EDGAR |
| 2024-03-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/award (A): 10,048 @ $0 · Sale (S): 5,140 @ $17.90 · Grant/award (A): 89,516 (derivative) @ $0 · Grant/award (A): 27,460 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,107 · Sale (S): 624 @ $24.67 · Option exercise (M): 1,107 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | ACADIA PHARMACEUTICALS INC (ACAD) | Option exercise (M): 1,287 · Sale (S): 731 @ $29.96 · Option exercise (M): 1,287 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1891900 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →